Johns Hopkins Dermatology Expands Advanced Care for Inflammatory and Autoimmune Skin Conditions with Addition of XTRAC® Excimer Laser

Latest STRATA customer strengthens academic leadership in XTRAC excimer laser treatment for psoriasis, vitiligo, and atopic dermatitisHORSHAM, Pa., Feb. 18, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: SSKN), a ...
MyChesCo on MSN

STRATA cites study on excimer laser for psoriasis

HORSHAM, PA — STRATA Skin Sciences Inc. (NASDAQ: SSKN) said a February 2026 systematic review and meta-analysis published in the Journal of Drugs in Dermatology found that 308 nm excimer ...
Taiwan News

STRATA Skin Sciences Highlights Meta-Analysis Confirming Clinical Efficacy of 308 nm Excimer Laser for Plaque Psoriasis

The February 2026 meta-analysis confirms that 308 nm Excimer Laser therapy, reliably produces significant improvement in plaque psoriasis. STRATA Skin Sciences remains committed to advancing clinical ...
Seeking Alpha

STRATA Skin Sciences Announces CMS Recognition of Expanded CPT Codes for Inflammatory and Autoimmune Dermatologic Conditions with Company Anticipating Wider Excimer Adoption ...

HORSHAM, Pa., Nov. 06, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (SSKN), a global leader in excimer laser therapy for inflammatory and autoimmune dermatologic diseases, today announced that ...
Seeking Alpha

STRATA Skin Sciences IP Portfolio Holds Exclusivity in Combination Therapies of Its XTRAC Excimer Laser with JAK Inhibitors, Systemic and Biologic Drugs, Bolstering Expansion ...

HORSHAM, Pa., Sept. 02, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the ...
KTLA

Strata continues to work closely with CMS to ensure a rapid implementation of the extended codes

HORSHAM, Pa., Sept. 02, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and ...